Carla Barrientos Risso

Statistics

Publications

Citations

165

H-Index

Active since

2022

Affiliations

University of Miami(Current)

Nurix (United States)

Sylvester Comprehensive Cancer Center

Memorial Sloan Kettering Cancer Center

Rockefeller University

Carla Barrientos Risso is an author at University of Miami specializing in tyrosine kinase inhibitors, btk inhibitors, and receptor tyrosine kinase signaling.

ORCID

Publications per year

2022–2024

Publications

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

Skye Montoya, Jessie Bourcier, Mark Noviski et al. · Science · 2024 · 148 citations · Full text

Medicine, Molecular Biology, Oncology +15

Kinase Dead BTK Mutations Confer Resistance to Covalent and Noncovalent BTK Inhibitors but Are Susceptible to Clinical Stage BTK Degraders

Skye Montoya, Jessie Bourcier, Meghan C. Thompson et al. · Blood · 2022 · 17 citations

Medicine, Molecular Biology, Pharmacology +15

1–2 of 2